Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004489 · ClinicalTrials.gov registry record · NA
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
A NA study, sponsored by University of North Carolina.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00004489 is a NA study that has completed, run by University of North Carolina. The registered enrollment target is 60 participants.
The verdict
NCT00004489, a NA study, has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the bioavailability and biologic effect of alendronate on bone metabolism in patients with cystic fibrosis. II. Assess the safety and efficacy of this treatment regimen in improving osteoporosis in this patient population.
Interventions
- DRUG alendronate sodium
- DRUG cholecalciferol
- DRUG calcium carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1998-10 |
| Est. Completion | 2002-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004489
The ClinicalTrials.gov registry entry for NCT00004489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which alendronate sodium is the first listed.
NCT00004489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004489 about?
NCT00004489 is a clinical study titled "Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis". OBJECTIVES: I. Determine the bioavailability and biologic effect of alendronate on bone metabolism in patients with cystic fibrosis. II. Assess the safety and efficacy of this treatment regimen in improving osteoporosis in this patient population.
What is the current status of trial NCT00004489?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 1998-10. Estimated completion is 2002-09.
What interventions are being tested in trial NCT00004489?
The interventions under investigation include: alendronate sodium (DRUG), cholecalciferol (DRUG), calcium carbonate (DRUG).
Who is sponsoring clinical trial NCT00004489?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.